Long-term Outcomes of Cabotegravir-Rilpivirine Long-Acting Injectable Initiated in People with HIV with Recent Viremia: A National VHA Cohort Study

Conference Reports for NATAP

IDSA
ID Week 2026
October 21-24
Washington, DC


Long-term Outcomes of Cabotegravir-Rilpivirine Long-Acting Injectable Initiated in People with HIV with Recent Viremia: A National VHA Cohort Study

	IDSA 2026 October 21-24 Wash DC